Plasmid-Mediated Carbapenemase Dissemination in Enterobacter cloacae: Molecular Insights from Guangdong, 2022–2024

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) pose a critical threat to global public health, with Enterobacter cloacae (CREC) emerging as a major contributor to multidrug-resistant infections in healthcare settings. The COVID-19 pandemic further complicated this landscape by increasing antibiotic exposure and disrupting infection control measures. While carbapenemase-encoding genes (CEGs) are recognized as central drivers of resistance, their detailed transmission dynamics—especially the role of plasmids—remained poorly characterized in the context of pandemic-related healthcare pressures.

The study by Chen et al. (2025) addressed this gap by systematically analyzing CEG carriage, localization, and transmission in CREC isolates collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024. Their work interrogated both the molecular epidemiology and the horizontal/vertical transfer potential of resistance determinants during a period of heightened clinical complexity.

Key Innovation from the Reference Study

This research is distinguished by its comprehensive dissection of CEG distribution across both chromosomal and plasmid compartments in CREC, with a particular focus on the epidemiologically dominant blaNDM-1 gene. By integrating PCR-based genotyping, conjugation experiments, and plasmid elimination protocols, the authors directly quantified the frequency and transferability of key carbapenemase genes. Additionally, the study combined genotyping (ERIC-PCR) and mobile genetic element analysis to map the diversity and spread of resistant clones across multiple hospital departments and patient cohorts.

Importantly, the study highlights the preeminent role of plasmid-mediated transmission, showing a 95.65% success rate for CEG transfer via conjugation, and identifies a high prevalence of mobile genetic elements such as ISEcp1, which facilitate gene mobility and persistence.

Methods and Experimental Design Insights

• Sample Collection: 54 CREC isolates were obtained from multiple wards and specimen types (notably sputum) in eight tertiary hospitals, providing a robust cross-sectional representation during the pandemic period.
• Genetic Characterization: PCR assays targeted major carbapenemase genes (blaNDM-1, blaIMP, blaKPC-2), and their loci (plasmid vs. chromosome) were determined using a variable temperature SDS plasmid curing method.
• Conjugation and Transferability: Plasmid conjugation experiments measured the horizontal transfer rates of CEGs, while ERIC-PCR and software-based genotyping mapped clonal relationships.
• Antibiotic Susceptibility: Broth microdilution assessed resistance profiles against a spectrum of antimicrobials, correlating genotype with phenotype.
• Mobile Element Typing: The presence of six mobile genetic elements was surveyed, with a focus on elements known to mediate gene mobility and recombination.

Protocol Parameters

• Plasmid selection assay concentrations: For molecular biology research, chloramphenicol is typically applied at 25 μg/ml for stringent plasmids and 170 μg/ml for relaxed plasmids, as referenced in product information.
• Plasmid elimination method: Variable temperature SDS curing is deployed to distinguish chromosomal versus plasmid gene carriage, as applied in the study.
• Conjugation protocol: Plasmid transfer frequency is quantified via conjugation with recipient strains under selective antibiotic pressure (often using an antibiotic such as chloramphenicol in parallel molecular biology protocols).
• Storage and handling: Chloramphenicol solutions should be stored at 4°C for short-term use and the solid form at -20°C for long-term stability, avoiding prolonged storage of reconstituted solutions for optimal integrity (see product guidelines).

Core Findings and Why They Matter

The investigation revealed that 85.19% of CREC isolates harbored carbapenemase-encoding genes, with blaNDM-1 being the most prevalent. Notably, 46.30% of strains carried blaNDM-1 exclusively on plasmids, and 33.33% on both plasmids and chromosomes. The study also detected blaIMP and the combination of blaNDM-1 + blaKPC-2, though at much lower frequencies. The conjugation experiments demonstrated a remarkably high transfer rate for plasmid-mediated CEGs—95.65% overall, and 95.45% specifically for blaNDM-1—while blaKPC-2 did not transfer under the tested conditions.

Antimicrobial susceptibility testing showed that CEG-positive isolates had significantly higher resistance rates to multiple drug classes, confirming the clinical threat posed by these strains. The most common mobile genetic element, ISEcp1, was found in 87.04% of isolates, underlining the molecular mechanisms enabling rapid gene spread. Genotyping revealed 17 distinct CREC genotypes, with certain clones (type E and G) widely distributed across different hospitals, suggesting successful nosocomial dissemination.

Demographically, CEG-positive CREC was most frequently detected in male and elderly patients, particularly in respiratory medicine wards and sputum samples, offering critical insights for targeted surveillance and infection control.

These findings underscore the importance of continued molecular monitoring, as plasmid-driven horizontal gene transfer remains a principal factor in the acceleration and persistence of multidrug resistance among clinical Enterobacter cloacae isolates, especially during periods of healthcare system stress such as the COVID-19 pandemic. The results offer actionable epidemiological data for designing more effective containment strategies.

Comparison with Existing Internal Articles

Recent internal articles such as "Chloramphenicol in Modern Molecular Biology: Mechanisms,..." and "Chloramphenicol in Plasmid Transmission Research: Mechani..." provide foundational understanding of chloramphenicol's mechanism as a protein synthesis inhibitor at the bacterial 50S ribosomal subunit and its use in plasmid selection assays. These articles highlight how chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide) serves as a stringent selection agent and a model inhibitor in studies of resistance gene mobilization.

While these internal resources focus on the mechanistic and methodological use of chloramphenicol in molecular biology workflows, the current reference study by Chen et al. uniquely contextualizes these mechanisms within a real-world clinical epidemiology framework, demonstrating how plasmid-borne resistance determinants (such as blaNDM-1) disseminate under selective pressures that may be recapitulated in laboratory selection assays. For researchers investigating the interplay between antimicrobial agents, plasmid biology, and resistance dynamics, the synergy between the clinical findings and molecular protocols is especially instructive.

Limitations and Transferability

This study's strengths lie in its multi-center design and integration of molecular, phenotypic, and epidemiologic data. However, the sample size (n=54) and the restriction to a single province may limit generalizability beyond the sampled hospitals. The focus on a relatively short surveillance period (December 2022–June 2024) provides a contemporary snapshot but may not capture longer-term evolutionary trends. Furthermore, while conjugation rates were high in vitro, actual horizontal transfer frequencies in complex clinical environments may be influenced by additional factors such as microbial competition and host immunity. The study does not address the functional consequences of specific mobile element variants or the in vivo fitness of CEG-positive clones.

Nevertheless, the methodologies and findings—particularly regarding plasmid localization, gene transfer, and the use of selection systems—are broadly transferable to molecular microbiology labs investigating resistance gene dissemination, and offer a template for future surveillance in other regions.

Research Support Resources

For researchers aiming to model plasmid-mediated resistance transfer or to perform stringent plasmid selection assays, Chloramphenicol (SKU A2512) provides a validated, high-purity reagent for inhibiting bacterial protein synthesis via the 50S ribosomal subunit. Its application in molecular biology workflows, as described above and in related internal protocols, can facilitate robust selection and experimental reproducibility in studies of resistance gene mobility. As always, solutions should be freshly prepared and handled according to stability guidelines to ensure reliable results.